Trial Profile
A Prospective, Randomized, Multicenter, Open, Blinded Endpoint (PROBE), Clinical Trial to Assess the Renal and Humoral Effects of Sevelamer Carbonate in Patients With Chronic Kidney Disease and Residual Proteinuria Despite Best Available Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary) ; Irbesartan; Ramipril
- Indications Proteinuria
- Focus Therapeutic Use
- Acronyms ANSWER
- 09 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Mar 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
- 04 Nov 2013 New trial record